Bray Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $3.33M | Sell |
33,515
-6,091
| -15% | -$628K | 0.9% | 30 |
|
|
2024
Q3 | $4.5M | Sell |
39,606
-732
| -2% | -$87K | 1.1% | 25 |
|
|
2024
Q2 | $4.99M | Sell |
40,338
-447
| -1% | -$57.6K | 1.25% | 20 |
|
|
2024
Q1 | $5.38M | Sell |
40,785
-243
| -0.6% | -$30K | 1.37% | 20 |
|
|
2023
Q4 | $4.47M | Buy |
41,028
+195
| +0.5% | +$20.2K | 1.24% | 22 |
|
|
2023
Q3 | $4.2M | Sell |
40,833
-81
| -0.2% | -$8.73K | 1.28% | 23 |
|
|
2023
Q2 | $4.72M | Sell |
40,914
-1,461
| -3% | -$166K | 1.42% | 18 |
|
|
2023
Q1 | $4.51M | Sell |
42,375
-548
| -1% | -$59.2K | 1.32% | 22 |
|
|
2022
Q4 | $4.76M | Sell |
42,923
-1,956
| -4% | -$200K | 1.48% | 17 |
|
|
2022
Q3 | $3.87M | Sell |
44,879
-84
| -0.2% | -$7.5K | 1.21% | 24 |
|
|
2022
Q2 | $4.1M | Buy |
44,963
+362
| +0.8% | +$32.1K | 1.22% | 24 |
|
|
2022
Q1 | $3.66M | Sell |
44,601
-237
| -0.5% | -$18.7K | 0.94% | 34 |
|
|
2021
Q4 | $3.44M | Buy |
44,838
+837
| +2% | +$66.7K | 0.84% | 38 |
|
|
2021
Q3 | $3.31M | Buy |
44,001
+389
| +0.9% | +$29.6K | 0.85% | 39 |
|
|
2021
Q2 | $3.39M | Buy |
43,612
+2,174
| +5% | +$162K | 0.87% | 36 |
|
|
2021
Q1 | $3.05M | Buy |
41,438
+1,894
| +5% | +$140K | 0.84% | 41 |
|
|
2020
Q4 | $3.09M | Buy |
39,544
+1,621
| +4% | +$124K | 0.9% | 36 |
|
|
2020
Q3 | $3M | Buy |
37,923
+609
| +2% | +$47.7K | 1.06% | 30 |
|
|
2020
Q2 | $2.75M | Sell |
37,314
-653
| -2% | -$49.2K | 1.06% | 28 |
|
|
2020
Q1 | $2.79M | Buy |
37,967
+6
| +0% | +$472 | 1.28% | 23 |
|
|
2019
Q4 | $3.29M | Sell |
37,961
-170
| -0.4% | -$14K | 1.17% | 30 |
|
|
2019
Q3 | $3.06M | Sell |
38,131
-2,661
| -7% | -$213K | 1.2% | 26 |
|
|
2019
Q2 | $3.26M | Sell |
40,792
-819
| -2% | -$62.7K | 1.26% | 24 |
|
|
2019
Q1 | $3.3M | Sell |
41,611
-97
| -0.2% | -$7.25K | 1.37% | 23 |
|
|
2018
Q4 | $3.04M | Sell |
41,708
-366
| -0.9% | -$25.8K | 1.52% | 20 |
|
|
2018
Q3 | $2.85M | Sell |
42,074
-28
| -0.1% | -$1.78K | 1.26% | 25 |
|
|
2018
Q2 | $2.44M | Buy |
42,102
+961
| +2% | +$54.2K | 1.14% | 27 |
|
|
2018
Q1 | $2.14M | Buy |
41,141
+3,746
| +10% | +$202K | 1% | 31 |
|
|
2017
Q4 | $2.01M | Sell |
37,395
-2,914
| -7% | -$162K | 0.96% | 43 |
|
|
2017
Q3 | $2.46M | Sell |
40,309
-905
| -2% | -$54.9K | 1.3% | 27 |
|
|
2017
Q2 | $2.52M | Sell |
41,214
-473
| -1% | -$28.8K | 1.38% | 29 |
|
|
2017
Q1 | $2.53M | Buy |
41,687
+952
| +2% | +$57.8K | 1.43% | 27 |
|
|
2016
Q4 | $2.29M | Buy |
40,735
+753
| +2% | +$44.1K | 1.37% | 29 |
|
|
2016
Q3 | $2.38M | Buy |
39,982
+3,701
| +10% | +$216K | 1.44% | 27 |
|
|
2016
Q2 | $2M | Buy |
36,281
+1,866
| +5% | +$99.3K | 1.24% | 34 |
|
|
2016
Q1 | $1.74M | Buy |
34,415
+2,630
| +8% | +$129K | 1.51% | 31 |
|
|
2015
Q4 | $1.6M | Buy |
31,785
+25,928
| +443% | +$1.31M | 1.02% | 39 |
|
|
2015
Q3 | $276K | Buy |
5,857
+4,285
| +273% | +$228K | 0.18% | 102 |
|
|
2015
Q2 | $85K | Buy |
+1,572
| New | +$88.2K | 0.05% | 182 |
|
Other funds holding MRK
Bray Capital Advisors's MRK Position: Q4 2024 in Review
Bray Capital Advisors reduced its Merck (MRK) stake by 15% in Q4 2024, selling an estimated $628K and leaving 33,515 shares worth $3.33M. The position accounts for 0.9% of the portfolio, ranked #30.
Bray Capital Advisors first reported a position in MRK in Q2 2015 and has held it in 39 quarters since. The position peaked at $5.38M in Q1 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.
- Bray Capital Advisors held 33,515 shares of Merck worth $3.33M as of Q4 2024.
- Bray Capital Advisors sold 6,091 Merck shares in Q4 2024, an estimated $628K.
- Merck made up 0.9% of Bray Capital Advisors's portfolio in Q4 2024, its #30 holding.
- Bray Capital Advisors first reported a position in Merck in Q2 2015 and has held it in 39 quarters since.
- Bray Capital Advisors's Merck position peaked at $5.38M in Q1 2024.
- 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.
Based on Bray Capital Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.